Mount Sinai Study Finds That Blood Clotting Drug Commonly Used for Orthopedic Surgeries Does Not Increase Complications for High-Risk Patients

Mount Sinai Researchers Find That Tranexamic Acid, a Blood Clotting Drug Commonly Used for Orthopedic Surgeries, Does Not Increase Complications for High-Risk Patients

Read more

Impaired Blood Clotting May Explain Higher COVID-19 Risk

A new review suggests that higher-than-normal levels of an enzyme involved in blood clot prevention may be a common risk factor for developing COVID-19—a respiratory disease caused by the novel coronavirus SARS-CoV-2—in some populations. The review is published in Physiological Reviews.

Read more